Jaspreet Mathur - 20 May 2022 Form 3 Insider Report for Limitless X Holdings Inc. (VYBE)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Jaspreet Mathur
Issuer symbol
VYBE
Transactions as of
20 May 2022
Transactions value $
$0
Form type
3
Filing time
29 Jul 2022, 15:55:40 UTC
Next filing
31 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VYBE Common Stock, par value $0.001 per share 72,265,000 20 May 2022 Direct F1
holding VYBE Series A Preferred Stock 500,000 20 May 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 20, 2022, pursuant to a Share Exchange Agreement dated May 11, 2022 (the "Agreement") by and between Limitless X Holdings Inc. ("Limitless") and Bio Lab Naturals Inc. (the "Issuer"), the reporting person exchanged 37,250,000 shares of Limitless common stock ("Company Shares") for 72,265,000 shares of the common stock of the Issuer (the "Exchange Shares") with the exchange ratio being 1.94 Exchange Shares for each Company Share.
F2 On May 20, 2022, pursuant to the Agreement, the reporting person purchased Series A Preferred Stock for a price of $0.80 per share. Each share of Series A Preferred Stock is convertible into two shares of the Issuer's common stock.